Home › Non-Small Cell Lung Cancer › Illinois › Peoria
Non-Small Cell Lung Cancer clinical trials in Peoria, IL
21 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Peoria (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
RecruitingPhase 2
- Illinois CancerCare-Peoria, Peoria
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria
- OSF Saint Francis Medical Center, Peoria
- and 3 more
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
RecruitingPhase 2/3
- OSF Saint Francis Medical Center, Peoria
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
RecruitingPhase 3
- Illinois Cancer Care ( Site 7000), Peoria
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
RecruitingPhase 3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RecruitingPhase 3
- Illinois Cancer Care, Peoria
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RecruitingPhase 3
- Illinois Cancer Care, Peoria
- Illinois CancerCare- Pekin, Pekin · 9 mi away
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Illinois CancerCare, P.C., Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- Illinois CancerCare, Peoria
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RecruitingPhase 3
- OSF Saint Francis Medical Center, Peoria
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- and 1 more
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
RecruitingPhase 1
- OSF Health Care, Peoria
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RecruitingPhase 1
- OSF Saint Francis Medical Center, Peoria
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
RecruitingPhase 1
- OSF Healthcare System; Saint Francis Medical Center, Peoria
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RecruitingPhase 1
- St. Francis Medical Center (OSF Healthcare), Peoria
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
RecruitingPhase 1
- OSF Healthcare Cancer Institute, Peoria
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Peoria
- Lung Cancer12 studies
- Colorectal Cancer12 studies
- Prostate Cancer9 studies
- Heart Failure8 studies
- Breast Cancer8 studies
- Ovarian Cancer7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Metastatic Cancer7 studies
- Pancreatic Cancer7 studies
- Cancer (all types)7 studies
- Melanoma6 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.